This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations of Yongzhen Li in Chronic Prostatitis Diagnosis and Treatment
Introduction
Yongzhen Li is an innovative inventor based in Jiangsu, China. He has made significant contributions to the field of medical diagnostics and treatment, particularly concerning chronic prostatitis and chronic pelvic pain syndromes (CP/CPPS). His work focuses on the application of TRPM8 protein and its related peptide fragments.
Latest Patents
Yongzhen Li holds a patent for the "Application of TRPM8 protein, related peptide fragment and their antibodies." This patent describes a TRPM8 related peptide fragment, which includes an amino acid sequence as shown in SEQ ID No: 1-18. The invention provides a method for diagnosing CP/CPPS by detecting the levels of TRPM8 protein molecules, TRPM8 related peptide fragments, and their antibodies. This diagnostic approach effectively distinguishes CP/CPPS from other prostate diseases. Furthermore, the invention outlines a therapeutic method involving the intravenous or subcutaneous injection of TRPM8 protein or related polypeptide fragments, which can significantly relieve clinical symptoms of CP/CPPS.
Career Highlights
Yongzhen Li has dedicated his career to advancing medical science through innovative research and development. His patent reflects his commitment to improving diagnostic and therapeutic options for patients suffering from chronic prostatitis. His work has the potential to enhance the quality of life for many individuals affected by this condition.
Collaborations
Yongzhen Li has collaborated with notable colleagues, including Lei Han and Xiaohui Zhou. These partnerships have contributed to the development and refinement of his innovative approaches in the medical field.
Conclusion
Yongzhen Li's contributions to the diagnosis and treatment of chronic prostatitis through his innovative patent demonstrate his significant impact on medical science. His work not only aids in effective diagnosis but also offers potential therapeutic solutions for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile